The emerging role of microRNAs in resistance to lung cancer treatments.

MacDonagh, Lauren; Gray, Steven G; Finn, Stephen P; Cuffe, Sinead; O'Byrne, Kenneth J; Barr, Martin P

MacDonagh, Lauren; Gray, Steven G; Finn, Stephen P; Cuffe, Sinead; O'Byrne, Kenneth J; Barr, Martin P.

Afiliação

MacDonagh L; Thoracic Oncology Research Group, School of Clinical Medicine, Institute of Molecular Medicine, Trinity Centre for Health Sciences, St James's Hospital & Trinity College Dublin, Ireland. Electronic address: lmacdona@tcd.ie.
Gray SG; Thoracic Oncology Research Group, School of Clinical Medicine, Institute of Molecular Medicine, Trinity Centre for Health Sciences, St James's Hospital & Trinity College Dublin, Ireland. Electronic address: sgray@stjames.ie.
Finn SP; Thoracic Oncology Research Group, School of Clinical Medicine, Institute of Molecular Medicine, Trinity Centre for Health Sciences, St James's Hospital & Trinity College Dublin, Ireland; Department of Histopathology, St James's Hospital & Trinity College Dublin, Ireland. Electronic address:
Cuffe S; Thoracic Oncology Research Group, School of Clinical Medicine, Institute of Molecular Medicine, Trinity Centre for Health Sciences, St James's Hospital & Trinity College Dublin, Ireland. Electronic address: scuffe@stjames.ie.
O'Byrne KJ; Thoracic Oncology Research Group, School of Clinical Medicine, Institute of Molecular Medicine, Trinity Centre for Health Sciences, St James's Hospital & Trinity College Dublin, Ireland; Cancer & Ageing Research Program, Queensland University of Technology, Brisbane, Australia. Electronic ad
Barr MP; Thoracic Oncology Research Group, School of Clinical Medicine, Institute of Molecular Medicine, Trinity Centre for Health Sciences, St James's Hospital & Trinity College Dublin, Ireland. Electronic address: mbarr@stjames.ie.

Cancer Treat Rev ; 41(2): 160-9, 2015 Feb.

Article em En | MEDLINE | ID: mdl-25592062

Assuntos

Antineoplásicos/farmacologia; Resistencia a Medicamentos Antineoplásicos; Neoplasias Pulmonares/tratamento farmacológico; Neoplasias Pulmonares/genética; MicroRNAs/metabolismo; Inibidores da Angiogênese/farmacologia; Antimetabólitos Antineoplásicos/farmacologia; Antineoplásicos/uso terapêutico; Apoptose/efeitos dos fármacos; Apoptose/genética; Receptores ErbB/antagonistas & inibidores; Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos; Humanos; Neoplasias Pulmonares/mortalidade; Compostos de Platina/farmacologia; Tolerância a Radiação; Radioterapia Adjuvante; Ligante Indutor de Apoptose Relacionado a TNF/genética; Ligante Indutor de Apoptose Relacionado a TNF/metabolismo; Taxoides/farmacologia

Palavras-chave

Cancer therapies; Chemotherapy; Lung cancer; MicroRNA; Resistance

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / MicroRNAs / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Treat Rev Ano de publicação: 2015 Tipo de documento: Article País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google